市場調查報告書

特殊酵素的全球市場 - 趨勢分析、競爭市場佔有率、預測 (2016-2026年):各產品、類型、原料、用途、終端用戶、地區

Global Specialty Enzymes Market, By Product Type, By Source, By Applications, By End User,By Region; Trend Analysis, Competitive Market Share & Forecast, 2016-2026

出版商 Blueweave Consulting & Research Private Limited 商品編碼 951533
出版日期 內容資訊 英文 175 Pages
商品交期: 最快1-2個工作天內
價格
特殊酵素的全球市場 - 趨勢分析、競爭市場佔有率、預測 (2016-2026年):各產品、類型、原料、用途、終端用戶、地區 Global Specialty Enzymes Market, By Product Type, By Source, By Applications, By End User,By Region; Trend Analysis, Competitive Market Share & Forecast, 2016-2026
出版日期: 2020年04月01日內容資訊: 英文 175 Pages
簡介

全球特殊酵素市場規模將從2019年的8億1700萬美金,預計在2020年∼2026年的預測期間內將以8.7%的年複合成長率成長。長期性疾病的治療的酵素應用擴大,對實際的治療方法的需求增加,及胃的酵素的疾病的發生增加,是促進醫藥品,診斷,及生物科技研究的全球特殊酵素市場發展的重要要素。限制市場發展的問題僅限於由於化學品擁有和酶促雜質增加的安全性問題。

本報告提供全球特殊酵素市場相關調查,目前市場趨勢,對市場的影響要素,各市場區隔、各地區的市場分析與預測,並提供主要企業簡介等資訊。

第1章 調查組成架構

第2章 調查手法

第3章 摘要整理

第4章 全球特殊酵素市場:產業考察

  • 產業價值鏈分析
  • DROC分析
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 技術形勢/近幾年的開發
  • 法律規範
  • 企業的市場佔有率分析
  • 波特的五力分析
  • COVID 19的影響

第5章 全球特殊酵素市場概要

  • 市場規模、預測:以金額為準
    • 以金額為準
  • 市場佔有率、預測
    • 各產品類型
      • Acylases
      • Hydratases
      • Humulin
      • Oxidase
      • Lyases
      • 限制酵素
      • 連接梅
      • 聚合酵素
      • 解脂酵素
      • 澱粉酵素
      • 蛋白分解酵素
      • 去氫酶
      • 葡萄醣醛酸酶
    • 各原料
      • 微生物
      • 植物
      • 動物
    • 各用途
      • 製藥
      • 生物科技研究開發
      • 診斷
    • 各終端用戶
      • 醫藥品產業
      • 生物科技企業
      • 診斷實驗室
      • 教育&研究機關
      • 其他
    • 各地區
      • 北美
      • 歐洲
      • 亞太地區
      • 南美
      • 中東、非洲

第6章 北美的特殊酵素市場

  • 市場規模、預測:以金額為準
    • 以金額為準
  • 市場佔有率、預測
    • 各產品類型
    • 各原料
    • 各用途
    • 各終端用戶
    • 各國
      • 美國
      • 加拿大

第7章 歐洲的特殊酵素市場

  • 市場規模、預測:以金額為準
    • 以金額為準
  • 市場佔有率、預測
    • 各產品類型
    • 各原料
    • 各用途
    • 各終端用戶
    • 各國
      • 德國
      • 英國
      • 法國
      • 義大利
      • 西班牙
      • 其他歐洲

第8章 亞太地區的特殊酵素市場

  • 市場規模、預測:以金額為準
    • 以金額為準
  • 市場佔有率、預測
    • 各產品類型
    • 各原料
    • 各用途
    • 各終端用戶
    • 各國
      • 印度
      • 中國
      • 日本
      • 韓國
      • 其他亞太地區

第9章 南美的特殊酵素市場

  • 市場規模、預測:以金額為準
    • 以金額為準
  • 市場佔有率與預測
    • 各產品類型
    • 各原料
    • 各用途
    • 各終端用戶
    • 各國

第10章 中東及非洲的特殊酵素市場

  • 市場規模、預測:以金額為準
    • 以金額為準
  • 市場佔有率與預測
    • 各產品類型
    • 各原料
    • 各用途
    • 各終端用戶
    • 各國

第11章 企業簡介 (公司概要,財務矩陣,產品形勢,主要人物,主要競爭企業,聯絡原住所,及策略性展望)

  • Advanced Enzyme Technology Ltd
  • Affymetrix Inc.
  • Amano Enzyme
  • Bbi Enzymes Ltd.,
  • BASF
  • Codexis Inc.
  • 長瀨產業
  • Life Technologies
  • Roche Holding Ag.
  • Sanofi S.A.
  • 其他有潛力的企業
目錄
Product Code: BWC20047

The Global Specialty Enzymes market was worth USD 817 Mn in 2019, anticipated to grow with a CAGR of 8.7% during the forecast period 2020- 2026. Specialty enzymes have increased popularity in the current years due to their prospective applications in various industries such as biotechnology research and diagnostics, pharmaceutical. Specialty enzymes are proteins that perform as biocatalysts to quicken responses and produce the wanted results in pharmaceuticals and diagnostics responses. In the pharmaceutical industry, specialty enzymes play a leading role in drug preparation and drug delivery. Enzyme based pharmaceutical drug preparations are used for the action of long-lasting circumstances such as cancer and AIDS. Specialty enzymes have been extensively used in the biotechnology industry for research, chiefly in molecular biology. Specialty enzymes play a significant role in the finding of diseases such as cancer, cardiovascular diseases, and lysosomal disorders. The specialty enzymes obligatory for diagnostics has to be of the uppermost cleanliness and in small quantity, which effects the high cost and less acceptance of diagnostic enzymes.

The growing applications of enzymes in treatments for long-lasting diseases, increasing demand for real therapeutics and rising occurrences of gastric enzyme complaints are some of the critical factors that energy the development of the global specialty enzymes market for pharmaceuticals, diagnostics and biotechnology research. Issues confining the market development are limit to the chemical possessions and safety subjects rising due to the impurity of enzymes.

The increased request for pharmaceutical enzymes as one of the leading development factors for this market. The surge in strain and harmful diets are top to an increase in unusual metabolism and the occurrence of related sicknesses, which is growing the use and feeding of digestive enzymes. These peptic enzymes can be a standalone enzyme, or a grouping is of different proteins are progressively being used in pharmaceuticals and nutritious supplements to normalize the metabolism, thereby nurturing the market growth.

The global specialty enzymes market is expected to witness development over the estimated period. Specific harvest optimization and catalytic response possessions of specialty enzymes are predictable to initiate its request over the next six years. Pharmaceutical producers across the globe have combined these specialty enzymes because of their expanding applications, particularly in processing fine chemicals and pure pharmaceutical drugs. The varying trend towards the adoption of specialty enzymes to decrease reliance on conventional enzymes has been detected in the last few years. Hence, these enzymes are predictable to enter the overall specialty enzymes market over the predictable years. Specialty enzymes are largely used to manufacture drugs to give some fatal diseases such as cardiovascular diseases, cancer, and pain caused by age, asthma, and hay fever and lysosomal packing illnesses in the pharmaceutical industry. The growing commonness of such diseases, coupled with the growing geriatric population, particularly in the U.S., Europe, and Japan, is also predictable to have an optimistic effect on market growth.

Growth Drivers

Increasing prevalence of digestive disorders

Increasing the occurrence of digestive ailments such as indigestion and swellings and other disorders such as immunodeficiency and pain. Specialty enzymes allow the rapid and effective release of these difficulties, and it delivers a wide variety of applications across a variety of sections of the specialty enzymes is also funding definitely to the market growth.

Development of global pharmaceutical industry, growing number of biotechnology R&D

One of the latest drifts that will advance grip in the specialty enzymes market in the coming years is the growing savings in R&D. Researchers are growing their attention on many R&D activities that add value to the industry that comprises the identification and making of enzymes from fungi and microbes and growth of next-generation enzymes that can be cast-off across sectors and not only limited to the diagnosis or pharmaceutical segments.

Specialty Enzymes Market: Competitive Landscape

North America emerged as the largest regional specialty enzyme market owing to the presence of niche consumer markets and progressive technologies. U.S. grips a main share of the overall North America specialty enzyme market. Surge in population and growth in disposable income among customers in evolving markets of China and India is predictable to drive Asia Pacific specialty enzymes market. China, India and Brazil are expected to be the most profitable regional markets for specialty enzymes.

Some of the leading players operating in the global specialty enzymes market are Advanced Enzyme Technology Ltd. Affymetrix Inc., Advanced Enzyme Technology Ltd., Amano Enzyme Inc., Bbi Enzymes Ltd., Basf, Codexis Inc., Nagase & Co. Ltd., Life Technologies, Roche Holding Ag., and Sanofi S.A.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Market Breakdown & Data Triangulation
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary research respondent, By Region
  • 2.5. Assumption & Limitation

3. Executive Summary

4. Global Specialty Enzymes market Industry Insights

  • 4.1. Industry Value Chain Analysis
  • 4.2. DROC Analysis
    • 4.2.1. Growth Drivers
    • 4.2.2. Restraint
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. Technological Landscape/Recent Development
  • 4.4. Regulatory Framework
  • 4.5. Company Market Share Analysis, 2019
  • 4.6. Porter's Five Forces Analysis
    • 4.6.1. Bargaining Power of Suppliers
    • 4.6.2. Bargaining Power of Buyers
    • 4.6.3. Threat of New Entrants
    • 4.6.4. Threat of Substitutes
    • 4.6.5. Intensity of Rivalry
  • 4.7. Impact of COVID 19

5. Global Specialty Enzymes market Overview

  • 5.1. Market Size & Forecast by Value, 2016-2026
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type
      • 5.2.1.1. Acylases
      • 5.2.1.2. Hydratases
      • 5.2.1.3. Humulin
      • 5.2.1.4. Oxidase
      • 5.2.1.5. Lyases
      • 5.2.1.6. Restriction Enzyme
      • 5.2.1.7. Ligases
      • 5.2.1.8. Polymerase
      • 5.2.1.9. Lipase
      • 5.2.1.10. Amylase
      • 5.2.1.11. Protease
      • 5.2.1.12. Dehydrogenases
      • 5.2.1.13. Glucuronidases
    • 5.2.2. By Source
      • 5.2.2.1. Microorganism
      • 5.2.2.2. Plant
      • 5.2.2.3. Animal
    • 5.2.3. By Application
      • 5.2.3.1. Pharmaceutical
      • 5.2.3.2. Biotechnology Research And Development
      • 5.2.3.3. Diagnostics
    • 5.2.4. By End User
      • 5.2.4.1. Pharmaceutical Industries
      • 5.2.4.2. Biotechnological companies
      • 5.2.4.3. Diagnostic Labs
      • 5.2.4.4. Education and Research Institutes
      • 5.2.4.5. Others
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia Pacific
      • 5.2.5.4. Latin America
      • 5.2.5.5. Middle East & Africa

6. North America Specialty Enzymes Market

  • 6.1. Market Size & Forecast by Value, 2016-2026
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Source
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
      • 6.2.5.1. United States
      • 6.2.5.2. Canada

7. Europe Specialty Enzymes market

  • 7.1. Market Size & Forecast by Value, 2016-2026
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Source
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
      • 7.2.5.1. Germany
      • 7.2.5.2. United Kingdom
      • 7.2.5.3. France
      • 7.2.5.4. Italy
      • 7.2.5.5. Spain
      • 7.2.5.6. Rest of Europe

8. Asia Pacific Specialty Enzymes Market

  • 8.1. Market Size & Forecast by Value, 2016-2026
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Source
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
      • 8.2.5.1. India
      • 8.2.5.2. China
      • 8.2.5.3. Japan
      • 8.2.5.4. South Korea
      • 8.2.5.5. Rest of Asia Pacific

9. Latin America Specialty Enzymes Market

  • 9.1. Market Size & Forecast by Value, 2016-2026
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
      • 9.2.1.1. By Product Type
      • 9.2.1.2. By Source
      • 9.2.1.3. By Application
      • 9.2.1.4. By End User
      • 9.2.1.5. By Country
      • 9.2.1.5.1. Brazil
      • 9.2.1.5.2. Mexico
      • 9.2.1.5.3. Rest of Latin America

10. Middle East & Africa Specialty Enzymes Market

  • 10.1. Market Size & Forecast by Value, 2016-2026
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
      • 10.2.1.1. By Product Type
      • 10.2.1.2. By Source
      • 10.2.1.3. By Application
      • 10.2.1.4. By End User
      • 10.2.1.5. By Country
      • 10.2.1.5.1. Saudi Arabia
      • 10.2.1.5.2. UAE
      • 10.2.1.5.3. South Africa
      • 10.2.1.5.4. Rest of Middle East & Africa

11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

  • 11.1. Advanced Enzyme Technology Ltd
  • 11.2. Affymetrix Inc.
  • 11.3. Amano Enzyme Inc.
  • 11.4. Bbi Enzymes Ltd.,
  • 11.5. BASF
  • 11.6. Codexis Inc.
  • 11.7. Nagase & Co. Ltd.
  • 11.8. Life Technologies
  • 11.9. Roche Holding Ag.
  • 11.10. Sanofi S.A.
  • 11.11. Other Prominent Players

* Financial details in case of unlisted companies will be available as per data availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable.